EFTRW
eFFECTOR Therapeutics, Inc. Warrant
EFTRW
EFTRW
Delisted
EFTRW was delisted on the 2nd of July, 2024.
17 hedge funds and large institutions have $2.94M invested in eFFECTOR Therapeutics, Inc. Warrant in 2021 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 7 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
17
Holding in Top 10
–
Calls
$484K
Puts
–
Top Buyers
| 1 | +$88K | |
| 2 | +$21.9K | |
| 3 | +$12.1K | |
| 4 |
ICM
III Capital Management
Boca Raton,
Florida
|
+$8.34K |
| 5 |
PA
Parallel Advisors
San Francisco,
California
|
+$3K |
Top Sellers
| 1 | -$517K | |
| 2 | -$213K | |
| 3 | -$163K | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$91.2K |
| 5 |
AGM
Alpine Global Management
New York
|
-$65K |